Results 121 to 130 of about 30,955 (215)

Review of Guideline Recommendations for Optimal Anti-VEGF Therapy in Age-Related Macular Degeneration

Life
Neovascular age-related macular degeneration is a progressive, blinding macular disease that has become a burden both in healthcare systems and the global economy. The vascular endothelial growth factor (VEGF) is the main agent involved in the pathogenic
Andreea Dana Moraru, Ciprian Danielescu, Raluca Eugenia Iorga, Radu Lucian Moraru, Mihail Zemba, Daniel Constantin Branisteanu   +5 more
doaj   +1 more source

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Pharmaceuticals
Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people. Current pharmacological treatment in vascular AMD includes anti-VEGF agents, such as ranibizumab and aflibercept. Additionally, the off-label use of
João Estarreja, Priscila Mendes, Carina Silva, Pedro Camacho, Vanessa Mateus   +4 more
doaj   +1 more source

Ocular syphilis masquerading as refractory retinal diseases

BMC Infectious Diseases
Purpose To report two cases of syphilis masquerading as chronic refractory macular diseases. Case descriptions Two patients had been diagnosed with neovascular age-related macular degeneration (neovascular AMD) and diabetic macular edema (DME ...
Sung Who Park, Kye-Hyung Kim, Han Jo Kwon, Ik Soo Byon, Youan Hasan Khan, Quan Dong Nguyen   +5 more
doaj   +1 more source

Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration [PDF]

, 2018
Agarwal, Betel, Dong, Gehlbach, Gerrity, Gerrity, Ménard, Nakamura, Paraskevopoulou, Peled, Vlachos, Wong   +11 more
core   +2 more sources

Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration [PDF]

, 2018
Purpose: The aim of this work is to investigate the characteristics of eyes failing to maintain visual acuity (VA) receiving variable dosing ranibizumab for neovascular age-related macular degeneration (nAMD) after three initial loading doses. Methods: A
Ambresin, Aude, Deli, Angeliki, Mantel, Irmela, Mariani, Alessandro   +3 more
core  

Draft a protocol for an observational study for anti-VEGF therapy in age related macular degeneration [PDF]

, 2015
Μακρή, Όλγα
core   +1 more source

Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration. [PDF]

J Nucl Med
Schmidt I, Volkmer P, Müskens RPHM, van der Waaij AM, van Dam GM, Huiskamp EA, Nagengast WB.   +6 more
europepmc   +1 more source

Massive Submacular Hemorrhage Following Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Kaganovski A, Rostomian N, Shrier E.
europepmc   +1 more source

Efficacy of Faricimab in Neovascular Age-Related Macular Degeneration: A Single-Arm Systematic Review and Meta-Analysis. [PDF]

Ophthalmic Res
Karam M, Baeshen M, Alfuzaie R, Mohammad M, Alshatti A, Samet A, Paez-Escamilla M, Sun V.   +7 more
europepmc   +1 more source

Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Sci
Chakravarthy U, Csincsik L, Teo KYC, Munk MR, Grewal DS, Guymer RH, Jaffe GJ, Peto T, Sadda SR, Staurenghi G, Cheung CMG, International Retinal Imaging Society Research Group.   +11 more
europepmc   +1 more source